Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preseason Japanese cedar SLIT after long-term use in children with pollinosis (PLUS trial)
jRCTs041240112Active, not recruiting
- Sponsor
- National Hospital Organization
- Start
- Nov 2024
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of Japanese cedar sublingual immunotherapy in Japanese cedar pollinosis (2 arms), sponsored by National Hospital Organization. Started Nov 2024; status: active, not recruiting.
02
Drugs
Japanese cedar sublingual immunotherapy
03
Conditions
Japanese cedar pollinosis
Beyond the preview
Go deeper on jRCTs041240112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240112.